The overall concordance rate of EGFR mutation between two kinds of samples was 86.98%, indicating that pleural effusion may be an effective method to screen EGFR mutation for NSCLC patients in advanced stages [67]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.